Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

NACompletedINTERVENTIONAL
Enrollment

2,119

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2018

Conditions
Coronary Artery DiseaseAngina PectorisMyocardial Infarction
Interventions
DEVICE

Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)

Percutaneous coronary intervention with implantation of a sirolimus-eluting stent with a bioresorbable polymer for coronary artery disease

DEVICE

Everolimus-eluting stent with a durable polymer

Percutaneous coronary intervention with implantation of an everolimus-eluting stent with a durable polymer for coronary artery disease

Trial Locations (9)

1010

Service de cardiologie CHUV, Lausanne

1211

Hôpitaux Universitaires de Genève, Geneva

1708

HFR Freiburg, Fribourg

3010

Department of Cardiology, Bern University Hospital, Bern

4031

Universitätsklinik Basel, Basel

5000

Kantonsspital Aarau, Aarau

6004

Luzerner Kantonsspital, Lucerne

8055

Stadtspital Triemli, Zurich

9007

Kantonsspital St. Gallen, Sankt Gallen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biotronik AG

INDUSTRY

collaborator

University of Bern

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER